The Anticonvulsant Effect of the Benzodiazepine Antagonist, Ro 15–1788: An EEG Study in 4 Cases
- 1 January 1984
- journal article
- research article
- Published by S. Karger AG in European Neurology
- Vol. 23 (1) , 1-6
- https://doi.org/10.1159/000115669
Abstract
An EEG study was carried out in 4 epileptic patients. In each case, Ro 15-1788 caused the disappearance or marked reduction of the epileptic potentials. In 1 case the patient had been pretreated with diazepam; in the other cases there had been no prior benzodiazepine treatment. In the first case, it is possible that Ro 15-1788 acted by abolishing a paradoxical effect of diazepam; in the other cases, we postulate an intrinsic anticonvulsant effect of Ro 15-1788. This investigation would suggest further study of Ro 15-1788 in epileptic patients for clarification of its anticonvulsant properties. In addition, evaluation of its action on the sedation caused by benzodiazepine antiepileptic medication is suggested.Keywords
This publication has 4 references indexed in Scilit:
- RO 15–1788 ANTAGONIZES THE EFFECTS OF DIAZEPAM IN MAN WITHOUT AFFECTING ITS BIOAVAILABILITYBritish Journal of Anaesthesia, 1983
- First Clinical Investigation of the Benzodiazepine Antagonist Ro 15-1788 in Comatose PatientsEuropean Neurology, 1983
- RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.British Journal of Clinical Pharmacology, 1982
- Selective antagonists of benzodiazepinesNature, 1981